The document discusses a report on the rare disease genetic testing market. According to the report, the global rare disease genetic testing market is expected to reach $1.8 billion by 2027, growing at a CAGR of 10.6% from 2020 to 2027. The market is segmented by disease type, technology, specialty, end-use, and region. North America currently dominates the market, followed by Europe and Asia-Pacific. Key players in the rare disease genetic testing market include Qiagen, PerkinElmer, Roche Diagnostics, and Centogene AG.

1. Rare Disease Genetic Testing
Market
Market $1.8 Billion by 2027 | CAGR: 10.6%

2. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 2 -
“According to Polaris Market Research report, Rare Disease Genetic Testing market is witnessing major
innovations & transformations and is anticipated to reach $1.8 Billion, registering a CAGR of 10.6% during
the forecast period 2020 to 2027.
The global Rare Disease Genetic Testing market report sheds light on the key dynamics of the global market,
analyzing the data on a historical basis and forecasted data till the year 2027 The market analysis covered in
the report includes data in terms of value $1.8 Billion. The market overview section of the report covers the
global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market
dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the
market.
Rare Disease Genetic Testing Market Report Scope:
The global Rare Disease Genetic Testing market is segmented based on disease type, technology, specialty,
end-use, and region. The motive of the research report is to define market dynamics of different countries &
segments in the recent time and to forecast the values for the coming years. The report is specifically designed
to incorporate quantitative and qualitative aspects of the market within each country and region involved in
the study.
The report caters the extensive information regarding the driving factors & hurdles that will define the future
outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for
stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent
players shaping the overall development of the market.

3. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 3 -
BY DISEASE TYPE BY TECHNOLOGY BY SPECIALTY BY END-USE BY REGION
• Neurological
Disorders
• Immunological
Disorders
• Hematology
Diseases
• Endocrine &
Metabolism
Diseases
• Cancer
• Musculoskeletal
Disorders
• Cardiovascular
Disorders
• Dermatology
Diseases
• Others
• Next Generation
Sequencing
o Whole
Exome
Sequencing
o Whole
Genome
Sequencing
• Array Technology
• PCR - based Testing
• FISH
• Sanger Sequencing
• Karyotyping
• Molecular
Genetic
Testing
• Chromosomal
Genetic
Testing
• Biochemical
Genetic
Testing
• Research
Laboratories
& CROs
• Hospitals &
Clinics
• Diagnostic
Laboratories
• North America
(U.S.,
Canada)
• Europe
(France,
Germany,
UK, Italy,
Spain,
Netherlands,
Austria)
• Asia Pacific
(Japan,
China, India,
Malaysia,
Indonesia.
South
Korea)
• Latin America
(Brazil,
Mexico,
Argentina)
Middle East
& Africa
(Saudi
Arabia, UAE,
Israel, South
Africa)
COVID-19 Impact Analysis for Rare Disease Genetic Testing Market
COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long-
term effects are expected to influence the target industry growth over the forecast period. Our ongoing
research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues
and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior
and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the
interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts,
considering the COVID-19 impact on the market.
Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic
impacting the the Rare Disease Genetic Testing market in different regions and how leading players are
forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging
opportunities : Browse Detailed Research Report On Rare Disease Genetic Testing Market Analysis:
https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market
Regional Outlook

4. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 4 -
Among regional markets, the region emerged as the promising regional market with its higher revenue share
contribution. The growth in this regional market is primarily attributed to the ongoing technological
advancements in the industry, increasing economic stability, huge government investments, and growing
awareness related to the benefits of the product/service.
Competitive Landscape
The report offers a complete industry analysis while featuring the competitive landscape that includes
company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a
detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional
landscape, major investments, and details of historical, present, and projected revenues. According to Polaris
Market Research, the key players with a noteworthy dominance in the Rare Disease Genetic Testing market
include Qiagen, PerkinElmer, Roche Diagnostics, Shimadzu (Novilytic Labs), Ahlstrom-Munksjö,
Pall Corporation, Eastern Business Forms, Inc., ARCHIMEDlife, and Centogene AG.
Request for sample: https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-
testing-market/request-for-sample
Table of Contents
1. Introduction
1. Report Description
1. Objectives of the Study
2. Market Scope
3. Assumptions
2. Stakeholders
2. Executive Summary
1. Market Highlights
3. Research Methodology
1. Overview
1. Data Mining
2. Data Sources
1. Primary Sources
2. Secondary Sources
4. Rare Disease Genetic Testing Market Insights
1. Rare Disease Genetic Testing – Industry snapshot
2. Rare Disease Genetic Testing Market Dynamics

5. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 5 -
1. Drivers and Opportunities
1. Prevalence of rare diseases
2. Government backed funding
2. Restraints and Challenges
1. Lack of epidemiological data
3. Porter’s Five Forces Analysis
1. Bargaining Power of Suppliers (Moderate)
2. Threats of New Entrants: (Low)
3. Bargaining Power of Buyers (Moderate)
4. Threat of Substitute (Moderate)
5. Rivalry among existing firms (High)
4. PESTLE Analysis
5. Rare Disease Genetic Testing Market Industry trends
5. Rare Disease Genetic Testing Market Assessment by Disease Type
1. Key Findings
2. Introduction
1. Global Rare Disease Genetic Testing Market, By Disease Type, 2016 –
2027 (USD Million)
3. Neurological Disorders
1. Global Rare Disease Genetic Testing Market, by Neurological Disorders, by
Region, 2016- 2027 (USD Million)
4. Immunological Disorders
1. Global Rare Disease Genetic Testing Market, by Immunological Disorders,
by Region, 2016- 2027 (USD Million)
5. Hematology Diseases
1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by
Region, 2016- 2027 (USD Million)
6. Endocrine & Metabolism Diseases
1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism
Diseases, by Region, 2016- 2027 (USD Million)
7. Cancer
1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2016-
2027 (USD Million)
8. Musculoskeletal Disorders
1. Global Rare Disease Genetic Testing Market, by Musculoskeletal
Disorders, by Region, 2016- 2027 (USD Million)
9. Cardiovascular Disorders

6. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 6 -
1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders,
by Region, 2016- 2027 (USD Million)
10. Dermatology Diseases
1. Global Rare Disease Genetic Testing Market, by Dermatology Diseases, by
Region, 2016- 2027 (USD Million)
11. Other Rare Diseases
1. Global Rare Disease Genetic Testing Market, by Other Rare Diseases, by
Region, 2016- 2027 (USD Million)
6. Global Rare Disease Genetic Testing Market, by Technology
1. Key Findings
2. Introduction
1. Global Rare Disease Genetic Testing Market, By Technology, 2016 – 2027
(USD Million)
3. Next Generation Sequencing
1. Global Rare Disease Genetic Testing Market, by Next Generation
Sequencing, By Region, 2016- 2027 (USD Million)
2. Whole Exome Sequencing
1. Whole Exome Sequencing Market, By Region, 2016- 2027 (USD
Million)
3. Whole Genome Sequencing
1. Whole Genome Sequencing Market, By Region, 2016- 2027 (USD
Million
4. Array Technology
1. Global Rare Disease Genetic Testing Market, by Array Technology, by
Region, 2016- 2027 (USD Million)
5. PCR - based Testing
1. Global Rare Disease Genetic Testing Market, by PCR - based Testing, by
Region, 2016- 2027 (USD Million)
6. FISH
1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2016-
2027 (USD Million)
7. Sanger Sequencing
1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by
Region, 2016- 2027 (USD Million)
8. Karyotyping
1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region,
2016- 2027 (USD Million)
7. Global Rare Disease Genetic Testing Market, by Specialty
1. Key Findings

7. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 7 -
2. Introduction
1. Global Rare Disease Genetic Testing Market, By Specialty, 2016 – 2027
(USD Million)
3. Molecular Genetic Testing
1. Global Rare Disease Genetic Testing Market, by Molecular, By Region,
2016- 2027 (USD Million)
4. Chromosomal Genetic Testing
1. Global Rare Disease Genetic Testing Market, by Chromosomal, by Region,
2016- 2027 (USD Million)
5. Biochemical Genetic Tests
1. Global Rare Disease Genetic Testing Market, by Biochemical Genetic
Tests, by Region, 2016- 2027 (USD Million)
8. Rare Disease Genetic Testing Market Assessment by End Use
1. Key Findings
2. Introduction
1. Global Rare Disease Genetic Testing Market, By End Use, 2016 – 2027
(USD Million)
3. Research Laboratories & CROs
1. Global Rare Disease Genetic Testing Market, by Research Laboratories &
CROs, by Region, 2016- 2027 (USD Million)
4. Hospitals & Clinics
1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by
Region, 2016- 2027 (USD Million)
5. Diagnostic Laboratories
1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories,
by Region, 2016- 2027 (USD Million)
9. Rare Disease Genetic Testing Market Assessment by Geography
1. Key findings
2. Introduction
1. Rare Disease Genetic Testing Market Assessment, By Geography, 2016-
2027 (USD Million)
3. Rare Disease Genetic Testing Market – North America
1. North America: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. North America: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. North America: Rare Disease Genetic Testing Market, By Specialty, 2016 -
2027 (USD Million)

8. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 8 -
4. North America: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
5. Rare Disease Genetic Testing Market – U.S.
1. U.S.: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. U.S.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. U.S.: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. U.S.: Rare Disease Genetic Testing Market, By End Use, 2016- 2027
(USD Million)
6. Rare Disease Genetic Testing Market – Canada
1. Canada: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Canada.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Canada: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Canada: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
4. Rare Disease Genetic Testing Market – Europe
1. Europe: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. Europe.: Rare Disease Genetic Testing Market, By Technology, 2016- 2027
(USD Million)
3. Europe: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027
(USD Million)
4. Europe: Rare Disease Genetic Testing Market, By End Use, 2016- 2027
(USD Million)
5. Rare Disease Genetic Testing Market – UK
1. UK: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. UK.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. UK: Rare Disease Genetic Testing Market, By Specialty, 2016- 2027
(USD Million)
4. UK: Rare Disease Genetic Testing Market, By End Use, 2016- 2027
(USD Million)
6. Rare Disease Genetic Testing Market – France
1. France: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. France.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. France: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)

9. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 9 -
4. France: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
7. Rare Disease Genetic Testing Market – Germany
1. Germany: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Germany.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Germany: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Germany: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
8. Rare Disease Genetic Testing Market – Italy
1. Italy: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. Italy.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. Italy: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Italy: Rare Disease Genetic Testing Market, By End Use, 2016- 2027
(USD Million)
9. Rare Disease Genetic Testing Market – Spain
1. Spain: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Spain.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. Spain: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Spain: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
10. Rare Disease Genetic Testing Market – Netherlands
1. Netherlands: Rare Disease Genetic Testing Market, By Disease
Type, 2016- 2027 (USD Million)
2. Netherlands.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Netherlands: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. Netherlands: Rare Disease Genetic Testing Market, By End Use,
2016- 2027 (USD Million)
11. Rare Disease Genetic Testing Market – Austria
1. Austria: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Austria.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Austria: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)

10. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 10 -
4. Austria: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
5. Rare Disease Genetic Testing Market – Asia-Pacific
1. Asia Pacific: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. Asia Pacific.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. Asia-pacific: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Asia-pacific: Rare Disease Genetic Testing Market, By End Use, 2016- 2027
(USD Million)
5. Rare Disease Genetic Testing Market – China
1. China: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. China.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. China: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. China: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
6. Rare Disease Genetic Testing Market – India
1. India: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. India.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. India: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. India: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
7. Rare Disease Genetic Testing Market – Malaysia
1. Malaysia: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Malaysia.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Malaysia: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Malaysia: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
8. Rare Disease Genetic Testing Market – Japan
1. Japan: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Japan.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. Japan: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)

11. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 11 -
4. Japan: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
9. Rare Disease Genetic Testing Market – Indonesia
1. Indonesia: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Indonesia.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Indonesia: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. Indonesia: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
10. Rare Disease Genetic Testing Market – South Korea
1. South Korea: Rare Disease Genetic Testing Market, By Disease
Type, 2016- 2027 (USD Million)
2. South Korea.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. South Korea: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. South Korea: Rare Disease Genetic Testing Market, By End Use,
2016- 2027 (USD Million)
6. Rare Disease Genetic Testing Market – Middle East & Africa
1. Middle East & Africa: Rare Disease Genetic Testing Market, By Disease
Type, 2016- 2027 (USD Million)
2. Middle East & Africa.: Rare Disease Genetic Testing Market, By
Technology, 2016- 2027 (USD Million)
3. Middle East & Africa: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. Middle East & Africa: Rare Disease Genetic Testing Market, By End Use,
2016- 2027 (USD Million)
5. Rare Disease Genetic Testing Market – Saudi Arabia
1. Saudi Arabia: Rare Disease Genetic Testing Market, By Disease
Type, 2016- 2027 (USD Million)
2. Saudi Arabia.: Rare Disease Genetic Testing Market, By
Technology, 2016- 2027 (USD Million)
3. Saudi Arabia: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. Saudi Arabia: Rare Disease Genetic Testing Market, By End Use,
2016- 2027 (USD Million)
6. Rare Disease Genetic Testing Market – UAE
1. UAE: Rare Disease Genetic Testing Market, By Disease Type, 2016-
2027 (USD Million)
2. UAE.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. UAE: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)

12. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 12 -
4. UAE: Rare Disease Genetic Testing Market, By End Use, 2016- 2027
(USD Million)
7. Rare Disease Genetic Testing Market – Israel
1. Israel: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Israel.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. Israel: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Israel: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
8. Rare Disease Genetic Testing Market – South Africa
1. South Africa: Rare Disease Genetic Testing Market, By Disease
Type, 2016- 2027 (USD Million)
2. South Africa.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. South Africa: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. South Africa: Rare Disease Genetic Testing Market, By End Use,
2016- 2027 (USD Million)
7. Rare Disease Genetic Testing Market – Latin America
1. Latin America: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Latin America.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Latin America: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Latin America: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
5. Rare Disease Genetic Testing Market – Mexico
1. Mexico: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Mexico.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Mexico: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)
4. Mexico: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
6. Rare Disease Genetic Testing Market – Brazil
1. Brazil: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Brazil.: Rare Disease Genetic Testing Market, By Technology, 2016-
2027 (USD Million)
3. Brazil: Rare Disease Genetic Testing Market, By Specialty, 2016-
2027 (USD Million)

13. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 13 -
4. Brazil: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
7. Rare Disease Genetic Testing Market – Argentina
1. Argentina: Rare Disease Genetic Testing Market, By Disease Type,
2016- 2027 (USD Million)
2. Argentina.: Rare Disease Genetic Testing Market, By Technology,
2016- 2027 (USD Million)
3. Argentina: Rare Disease Genetic Testing Market, By Specialty,
2016- 2027 (USD Million)
4. Argentina: Rare Disease Genetic Testing Market, By End Use, 2016-
2027 (USD Million)
10. Competitive Landscape
1. Expansion and Acquisition Analysis
1. Expansion
2. Acquisitions
2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
1. Strand Life Sciences
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
2. Myriad Genetics
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
3. Quest Diagnostics Inc.
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
4. Centogene N.V.
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
5. Invitae Corporation
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking

14. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 14 -
4. Recent Development
6. Eurofins Scientific
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
7. Ambry Genetics
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
8. Macrogen, Inc.
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
9. Health Network Laboratories
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
10. Fulgent Genetics Inc.
1. Company Overview
2. Financial Performance
3. Services/Product Benchmarking
4. Recent Development
Access Press Release on Rare Disease Genetic Testing Market:
https://www.polarismarketresearch.com/press-releases/rare-disease-genetic-testing-market
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in
providing exceptional market intelligence and in-depth business research services for our clientele spread
across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the
industries of healthcare, technology, semi-conductors, and chemicals among various other industries present
around the world. We strive to provide our customers with updated information on innovative technologies,
high growth markets, emerging business environments, and the latest business-centric applications, thereby
helping them always to make informed decisions and leverage new opportunities. Adept with a highly
competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants,
we at Polaris endeavor to deliver value-added business solutions to our customers.

15. Rare Disease Genetic Testing Market Size Worth $1.8 Billion by 2027
- 15 -
E mail Id: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
Official Blog: http://polarismarketresearch.blogspot.com